PATENT CLAIM ANALYSIS

Application Number: 16093376
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "342000"]

Abstract:
Disclosed is a compound for treating fibrosis-related diseases, and specifically disclosed are the compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Claim (Index 2):
The compound, pharmaceutically acceptable salt and tautomer thereof of  claim 1 , wherein R is selected from H, F, Cl, Br, I, OH, CN, NH 2 , COOH, C(\u2550O)NH 2 , or selected from the group consisting of C 1-3  alkyl, C 1-3  alkyl-O\u2014, C 1-3  alkyl-S\u2014, C 1-3  alkyl-NH\u2014, N,N\u2032-di(C 1-3  alkyl)amino, C 3-6  cycloalkyl and 3-6-membered heterocycloalkyl, the C 1-3  alkyl, C 1-3  alkyl-O\u2014, C 1-3  alkyl-S\u2014, C 1-3  alkyl-NH\u2014, N,N\u2032-di(C 1-3  alkyl)amino, C 3-6  cycloalkyl and 3-6-membered heterocycloalkyl are optionally substituted with 1, 2 or 3 of R\u2032.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16325626', '16326976', '16066852', '16096848', '15750704']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8394795770925649
- 35 USC 102 Novelty (BERT): 0.5568448353954673
- Combined Prediction Score: 0.8112161029228552
- Mean Citation Score: 391.3555060000001
- Max Citation Score: 429.8432
- Similarity Product: 385.8205416187287

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test